Overexpression of c-fos in Helicobacter pylori-induced gastric precancerosis of Mongolian gerbil

World Journal of Gastroenterology

Volumn 9, Issue 3, 2003, Pages 521-524

  Yang, Yong Li ^a   Xu, Bo ^a   Song, Yu Gang ^a   Zhang, Wan Dai ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BIOTIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN C FOS; RNA; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; GENE AMPLIFICATION; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HOUSEKEEPING GENE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LAMINA PROPRIA; LYMPH FOLLICLE; MALE; NONHUMAN; PRECANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STOMACH ANTRUM; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STOMACH ULCER; SUBMUCOSA;

EID: 0037349702     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i3.521     Document Type: Article

References (49)

1. Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanshi M, Tomioka K, Nakamura S, Fujishima M. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: A special study regarding the methods for detecting Helicobacter pylori. Dig Dis Sci 1999; 44: 2027-2034
2. Meining AG, Bayerdorffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients. Eur J Gastroenterol Hepatol 1999; 11: 717-720
3. Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori Cag A and Vac A and the risk for gastric cancer. J Clin Pathol 1999; 52: 215-218
4. Danesh J. Helicobacter pylori infection and gastric cancer: Systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999; 13: 851-885
5. Harris RA, Owens DK, Witherell H, Parsonnet J. Helicobacter pylori and gastric cancer: What are the benefits of screening only for the Cag A phenotype of H. pylori? Helicobacter 1999; 4: 69-76
6. Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999; 34: 353-360
7. Scheiman JM, Cutler AF. Helicobacter pylori and gastric cancer. Am J Med 1999; 106: 222-226
8. Kuipers EJ. Review article: Exploring the link between Helicobacter pylori and gastric cancer. Alment Pharmacol Ther 1999; 13: 3-11
9. Alexander GA, Arng MC. Association of Helicobacter pylori infection with gastric cancer. Mil Med 2000; 165: 21-27
10. Zhuang XQ, Lin SR. Study on the relationship between Helicobacter pylori and gastric cancer. Shijie Huaren Xiaohua Zazhi 2000; 9: 206-207
11. Vandenplas Y. Helicobacter pylori infection. World J Gastroenterol 2000; 6: 20-31
12. Pan KF, Liu WD, Ma JL, Zhou T, Zhang L, Chang YS, You WC. Infection of Helicobacter pylori in children and mode of transmission in a high-risk area of gastric cancer. Shijie Huaren Xiaohua Zazhi 1998; 6: 42-44
13. Zhang L, Jiang J, Pan KF, Liu WD, Ma JL, Zhou T, Perez GT, Blaser MJ, Chang YS, You WC. Infection of Helicobacter pylori with cag A strain in a high-risk area of gastric cancer. Shijie Huaren Xiaohua Zazhi 1998; 6: 40-41
14. Zhuang XQ, Lin SR. Study on Helicobacter pylori infection in gastric cancer and precancerosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 710-711
15. Hu PJ. Helicobacter pylori and gastric cancer. Shijie Huaren Xiaohua Zazhi 1999; 7: 1-2
16. Huang XQ. Helicobacter pylori infection and gastrointestinal hormones: A review. World J Gastroenterol 2000; 6: 783-788
17. Shang SH, Zheng JW. Treatment on Helicobacter pylori-induced diseases. Shijie Huaren Xiaohua Zazhi 2000; 8: 556-557
18. Wang XH, Zhang WD, Zhang YL, Zeng JZ, Sun Y. Relationship between Hp infection and oncogene and tumor suppressor gene expression in gastric cancer and precancerosis. Shijie Huaren Xiaohua Zazhi 1998; 6: 516-518
19. Ye GA, Zhang WD, Liu LM, Shi L, Xu ZM, Chen Y, Zhou DY. Hp vac A gene and chronic gastritis. Shijie Huaren Xiaohua Zazhi 2001; 9: 593-594
20. Quan J, Fan XG. Experimental studies on Helicobacter pylori and gastric cancer. Shijie Huaren Xiaohua Zazhi 1999; 7: 1068-1069
21. Lu SY, Pan XZ, Peng XW, Shi ZL, Lin L, Chen MH. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases. Shijie Huaren Xiaohua Zazhi 2000; 8: 386-388
22. Xiao SD. Helicobacter pylori and gastric cancer. Shijie Huaren Xiaohua Zazhi 1998; 6: 4
23. Harry XH. Association between Helicobacter pylori and gastric cancer: Current knowledge and future research. World J Gastroenterol 1998; 4: 93-96
24. Zu Y, Shu J, Yang CM, Zhong ZF, Dai HY, Wang X, Qin GM. Study on Helicobacter pylori infection and risk of gastric cancer. Shijie Huaren Xiaohua Zazhi 1998; 6: 367-368
25. Cai L, Yu SZ, Zhang ZF. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China. World J Gastroenterol 2000; 6: 374-376
26. Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer 1999; 85: 699-677
27. Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein B, Moss SF. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cell. Cancer Res 1999; 59: 2277-2281
28. Gao H, Wang JY, Shen XZ, Liu JJ. Effect of Helicobacter pylori infection on gastric epithelial cell proliferation. World J Gastroenterol 2000; 6: 442-444
29. Hidekazu SU, Hiromasa IS. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol 2000; 15: D46-D54
30. Zhuang XQ, Lin SR. Research of Helicobacter pylori infection in precancerous gastric lesions. World J Gastroenterol 2000; 6: 428-429
31. Gu JZ, Hou TW, Wang XX. Study on precancerous gastric lesions induced by Helicobacter pylori. Shijie Huaren Xiaohua Zazhi 2001; 9: 111
32. Tischmeyer W, Grimm R. Activation of immediate early genes and memory formation. Cell Mol Life Sci 1999; 55: 564-574
33. Lennartsson J, Blume Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene 1999; 18: 5546-5553
34. Trauth JA, Seidler FJ, McCook EC, Slotkin TA. Persistent c-fos induction by nicotine in developing rat brain regions: Interaction with hypoxia. Pediatr Res 1999; 45: 38-45
35. Duan R, Porter W, Samudio I, Vyhidal C, Kladde M, Safe S. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol Endocrinol 1999; 13: 1511-1521
36. Morrissey JJ, Raney S, Heasley E, Rathinavelu P, Dauphinee M, Fallon JH. IRIDIUM exposure increase c-fos expression in the mouse brain only at levels which likely result in tissue heating. Neuroscience 1999; 92: 1539-1546
37. Hasebe T, Imoto S, Sasaki S, Tsubono Y, Mukai K. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: Proposal fibroadenoma, cellular variant. Pathol Int 1999; 49: 435-443
38. Whong WZ, Gao HG, Zhou G, Ong T. Genetic alterations of cancer-related genes in glass fiber-induced transformed cells. J Toxicol Environ Health 1999; 56: 397-404
39. Chen W, Dong Z, Valcic S, Timmermann BN, Bowden GT. Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 1999; 24: 79-84
40. Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumor cell proliferation. Oncogene 2001; 20: 2101-2111
41. Mitsuno Y, Yoshida H, Maeda S, Ogura K, Hirata Y, Kawabe T, Shiratori Y, Omata M. Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signaling pathway in gastric cancer cells. Gut 2001; 49: 18-22
42. He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and antagonists on colorectal carcinoma. World J Gastroenterol 1999; 5: 408-416
43. Yuan SL, Huang RM, Wang XJ, Song Y, Huang GQ. Reversing effect of Tanshinone on malignant phenotypes of human hepatocarcinoma cell line. World J Gastroenterol 1998; 4: 317-319
44. YH, Hu DR, Nie QH, Liu GD, Tan ZX. Study on activation and c-fos, c-jun expression of in vitro cultured human hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2000; 8: 299-301
45. Jiang LX, Fu XB, Sun TZ, Yang YH, Gu XM. Relationship between oncogene c-jun activation and fibrobl. Shijie Huaren Xiaohua Zazhi 1999; 7: 498-500
46. Chen BW, Wang HT, Liu ZX, Jia BQ, Ma QJ. Effect of exogenous EGF on proto-oncogene expression in experimental gastric ulcers. Shijie Huaren Xiaohua Zazhi 1999; 7: 504-506
47. Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN. C-fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRAC1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene 2001; 20: 1357-1367
48. Ma KS, Zhang FS, He ZP, Wanf SG, Zhong JH. Effect of CCK on cell apoptosis of bile duct neoplasms. Shijie Huaren Xiaohua Zazhi 2000; 8: 1312-1313
49. Salmi A, Carpen O, Rutanen E. The association between c-fos and c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer. Tumour Biol 1999; 20: 202-211